Massive Haemorrhage J Davies B Ferguson

Similar documents
Massive Haemorrhage P Donnelly B Ferguson

Blood transfusion in special situations and poly-trauma. Dr Marina Karakantza Consultant Haematologist in Transfusion Medicine, LTHT

TAYSIDE GUIDE TO MASSIVE TRANSFUSION/BLOOD LOSS

MANAGEMENT OF MASSIVE TRANSFUSION

Major Burns Debridement Case

REGIONAL AUDIT OF PLASMA PRODUCTS 2016

Alberta Health Services - Edmonton Zone Massive Hemorrhage Protocol

Significant Improvement In The Management Of Major Obstetric Haemorrhage With A Rotem Guided Algorithm Using Fibrinogen Concentrate

ANEMIA. Oral iron. IV iron gluconate (order set #233)

TRANSFUSION MANAGEMENT OF MASSIVE HAEMORRHAGE

HAEMOVIGILANCE. Ms. Emma O Riordan.

Robert Elshaw Transfusion Manager Hull and East Yorkshire Hospitals NHS Trust

EDUCATIONAL COMMENTARY MASSIVE TRANSFUSION PROTOCOL

Home truths... the clinical use of components in the UK. Jonathan Wallis. Platelets, FFP, Cryoprecipitate

Hospital Experience. Mike Herbert - Transfusion Laboratory Manager New Cross Hospital Wolverhampton

Postpartum Haemorrhage make sure you give enough fibrinogen!

BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

BLOOD TRANSFUSION PETER HUDSON CLINICAL SPECIALIST

Blood Product Utilization

The Next Big Thing. Dr Anne Weaver Consultant in Emergency Medicine & Pre-hospital Care Clinical Director for Trauma Royal London Hospital

Alternative Haemostatic Agents in the Management of Obstetric Haemorrhage

Looking after a Finite Resource. Adrian Ebbs Transfusion Laboratory Manager Queen Elizabeth Hospital King s Lynn

Current Evidence based management of Massive Haemorrhage

Applying ROTEM to the Management of Bleeding in Trauma

Coagulation and postpartum haemorrhage. Peter Collins Cardiff

Cryoprecipitate audit within six centres in New Zealand.

The evolution of TQIP Best Practices for Massive Transfusion

Managing Massive Transfusions in diverse Patient Populations in a Non-Metropolitan Area

What Can We Learn from Animal Models of Coagulopathy and Bleeding (about plasma transfusion)?

What could be better than a blood bank full of blood? Ways to reduce wastage. Mark Yazer, MD University of Pittsburgh University of Southern Denmark

General News. Product Notes. Instrument Notice HELENA SALES FORCE TO: FROM: SUBJECT: HELENA POINT OF CARE ROUND-UP/US DOMESTIC DATE: 9/1/2009

STANDARD BLOOD PRODUCTS AND SERVICES

Implementation of massive transfusion protocols to guide practice in severe bleeding- is your institution ready?

Clinical Procedure. ROTEM Trauma, Resuscitation. Princess Alexandra Hospital Emergency Department. 1 Introduction

Use of ROTEM from the Laboratory Perspective. A/Prof David Roxby SA Pathology

Disclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications

Obstetrical (OB) Hemorrhage Guidelines

Improving Outcomes of Cardiac Surgery with a Point-of-Care Based Transfusion Algorithm

CHANGE IN PLATELET USAGE

Optimising bleeding management: One hospital s experience DR DANIEL FAULKE

Why one size does NOT fit all. Presentation by: Nicola Main Date: 24 September 2013

Category Storage Shelf Life Additional Criteria

Single Unit Mandatory Training Workbook

Princess Alexandra Hospital Emergency Department. Clinical Procedure. 1 Introduction

Red Cell Transfusion LESSONS FROM TRAUMA

Emerging Use Of Rotational Thromboelastometry (ROTEM) in Trauma Resuscitation. Ashley Millham, CD, BSC CCPA

Strategies for transfusion therapy and monitoring

General News. Product Notes

Massive Transfusion Protocol (MTP)

Emergency and Perioperative Hemostasis Testing: Which Assays Provide Helpful Information. Wayne Chandler, MD Laboratory Medicine Seattle Children s

Debbie Asher Chief BMS, Norfolk and Norwich University Hospital SHOT Working Expert Group

Riastap (fibrinogen concentrate, human) Public Summary of Risk Management Plan (Extract from the EU Risk Management Plan Version 3.

Blood Management and Bedside Transfusion Solutions. Enhance patient safety. Maintain traceability. Reduce waste.

Laboratory investigation in the Bleeding Patient. Dr Craig Taylor Consultant Haematologist May 2016

REVIEW OF TRANEXAMIC ACID IN TRAUMA

The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management. Elham Khalaf Adeli

The Safe Carriage of Red Blood Cells in Aeromedical Retrievals

Consulted With; Post/Committee/Group Date Haematology Dr Shereen Elshazly (Lead for Anticoagulation) January 2016 Department of Anaesthesia

TSOAC Case Study 1. Question. TSOAC Case Study 1 Continued

Contents BLOOD TRANSFUSION. Blood Transfusion Laboratory Index

To enable the learner to develop an understanding of the various stages of Intraoperative Cell Salvage (ICS)

Presented by. Dave Dawson Hospital Services Manager NHSBT Newcastle. Too Much To Lose Durham 14/11/12

Coagulopathy Case-2. Andy Nguyen, M.D. 2009

Perioperative management of patients on warfarin requiring elective surgery Dr K Boyd, Mrs S Doyle

Disclosure. Hemophilia: The Royal Treatment. Objectives. Background. History of Hemophilia. Epidemiology 1/4/2018

Anticoagulation in VTE The Haematologist s Perspective. Dr. M.D. Maina FRCP Edin.

Acute Traumatic Coagulopathy

Management of Bleeding in the Anticoagulated Patient Short Snappers CSIM 2015 Elizabeth Zed, MD, FRCPC October 17, 2015

Patients who Decline Blood Products:- Haematological Aspects of Care. Dr Catherine Flynn Consultant Haematologist CWIUH

Blood Management and Bedside Transfusion Solutions. Enhance patient safety. Maintain traceability. Reduce waste.

Aim. To provide basic knowledge on the processing, testing and issue of blood donations by NHSBT

Page 1 of 7. Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc)

BAXTER HEALTHCARE v JOHNSON & JOHNSON WOUND MANAGEMENT

Procedure. Applies To: UNM Hospitals Responsible Department: Transfusion Medicine Effective date: 05/24/2018

NHSBT Portfolio of Blood Components and Guidance for their Clinical Use. Summary of Significant Changes. Purpose. Definitions. Applicable Documents

Blood Component Therapy and Apheresis

Clinical Use of Plasma for Transfusion. Irma Szymanski, MD Professor of Pathology, Emerita University of Massachusetts Medical School

Therapeutic monoclonal antibodies & blood transfusion Essential information for hospital transfusion laboratories, transfusion practitioners &

Blood is 55% Plasma (Liquid)

Primary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system

QUICK USER GUIDE CAPILLARY BLOOD INR TESTING FOR USING THE THROMBI-STAT MC1 WB INSTRUMENT MANCHESTER CAPILLARY REAGENT INTRODUCTION AND

BLOOD ADMINISTRATION PROTOCOL

Against this background, the use of multiple doses, principally double, continues. The purpose of this audit was to:-

Haematology and Blood Transfusion User Handbook

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin

Role of fibrinogen concentrate in coagulation management in complex cardio-vascular surgery

CURRENT PRACTICE IN HOSPITALS

Recombinant Factor VII vs Cryoprecipitate. Dr. M. Truter Moderator: Prof. Pretorius

Blood Bank Review. Case #1 ABO/Rh. Case #1 Antibody Screen. Is the ABO grouping discrepant? No Interpretation: O positive

Dr Kate Talks, Consultant Haematologist, Newcastle upon Tyne Hospitals NHS Trust Nov 2012

Instructions on proper usage to ensure safe blood transfusion By Julie G. Jackson MT(ASCP)SBB

Producing Blood Components from donated Whole blood, or The art of the Impossible? Ian Symonds, Manufacturing Manager NHSBT Colindale

Fibrinogen, haemostasis and postpartum haemorrhage. Ove Karlsson Sahlgrenska University Hospital Gothenburg, Sweden

Implementing Improvement. The Quick Guide to. Making the safety of patients everyone s highest priority

Factor Concentrates. More is better? Alexander Duncan MD Emory Medical Labs

Novel Anti-coagulant Agents. David G Hovord BA MB BChir FRCA Clinical Assistant Professor University of Michigan

ABO, Rh, HLA Antibodies Issues with Whole Blood NANCY M. DUNBAR, MD MEDICAL DIRECTOR, BLOOD BANK DARTMOUTH-HITCHCOCK MEDICAL CENTER, LEBANON, NH, USA

Andrew Schorr: Is there anything you ve been discussing that you d like to update people about now?

Transcription:

Massive Haemorrhage J Davies B Ferguson

What is Massive Haemorrhage (MH)? Difficult to apply rules as to how much blood loss defines a major haemorrhage. Easier to define how the patient s condition is responding to the blood loss. Clinicians commonly use a heart rate of 110 or more per minute and a falling blood pressure to 90 mmhg or less as meaning the patient is becoming shocked due to blood loss. However, there is no requirement to wait until heart rate rises or blood pressure falls before acting.

Why does each hospital have a Massive Haemorrhage Protocol? ADULT MASSIVE HAEMORRHAGE PROTOCOL In 2010 the National Patient Safety Agency highlighted a recurring theme of delays in blood provision in emergencies. From 2010, each hospital had to have a local MH protocol In the 4 years from 2006 to 2010 there were 11 deaths directly from the delay in blood provision All medical, nursing, laboratory and support staff must know where to find the protocol and have their knowledge supported by training and drills New Major Haemorrhage Guidelines in 2015 from the BCSH emphasise that laboratory staff should not wait for haematology consultant approval prior to releasing blood and blood components Do not delay definitive treatment e.g. surgery 150ml/min blood loss 50% circulating volume loss in 3 hrs Low BP secondary to bleeding Stop the bleeding + ABC Nominate staff member to communicate with Lab 2222 ACTIVATE MASSIVE HAEMORRHAGE PROTOCOL State clearly location and give extension number BLOOD PACK X4 Blood, X4 FFP (40 minutes to defrost) Send urgent bloods; FBC, coagulation screen, crossmatch (x2 if new patient) Nominate member of staff to act as runner to lab 1:1 Blood : FFP 1g Tranexamic Acid over 10 minutes, then 1g over 8 hours CELL SALVAGE & ROTEM Reassess after 4 units blood/ FFP and resend FBC & coagulation screen Patient stable? Stand down protocol TRANSFUSION TRIGGERS Platelets < 75x10 9 /l(< 100 in brain and spine injury) give platelets Fibrinogen <1.5g/l (<2 g/l if obstetric ) give cryoprecipitate or fibrinogen concentrate INR > 1.5/APTR>1.5 give FFP For patients on Warfarin/ NOAC / anti platelet agents see relevant section of policy

Communication between the Transfusion Laboratory and the Clinical team Emphasised in the national guideline The team leader in the clinical area should appoint a specific clinical member to co-ordinate communication with Transfusion Laboratory staff Depending on the number of staff working in the TL, a named team leader should be appointed for transfusion and this person should either take responsibility for communicating with the clinical team or appoint someone else to do this

What will the clinical team need from the lab? Blood Components Red cells Fresh Frozen Plasma Platelets Cryoprecipitate Good communication Rapid response Advice on component type, timings, availability (Consultant Haematologist)

Red Blood Cells Oxygen carrying capacity and improve haemostasis ( blood clotting) Rheological effect, axial flow

Fresh Frozen Plasma ( FFP) Contains coagulation factors, fibrinolytic factors and proteins important for oncotic pressure Advised to be used as part of the initial resuscitation in massive haemorrhage in a 1:1 ratio with RBC until coagulation results are available Once bleeding under control further FFP should be guided by abnormalities in coagulation laboratory tests, with a trigger of PT and/or APPT of more than 1.5 times normal

Cryoprecipitate Fibrinogen is one of the clotting factors vital for clot formation and it is reported that it is the first clotting factor to fall to critical levels in massive haemorrhage. Cryoprecipitate has 5 times more fibrinogen per unit than FFP A normal range of fibrinogen is between 1.5 to 4 g/l. If fibrinogen falls below 1.5g/l during a MH then it should be replaced with cryoprecipitate A typical adult dose is 2 units of pooled cryoprecipitate; this generally raises fibrinogen by 1g/l In obstetrics, fibrinogen levels in pregnant women increase to 4-6 g/l at term. This means a fibrinogen level of 2-3 g/l which would be reassuring in a non-pregnant woman may mean that fibrinogen is falling and consideration should be given to replacing fibrinogen if levels fall below 2g/l in obstetric cases

Platelets Low platelet levels are considered a late event in massive haemorrhage, seen only after a loss of at least 1.5 blood volumes The BCSH Guidelines (2015) suggest that if you need to order platelets from the Blood Transfusion Centre, that you order them when the platelet count falls below 100 x10 9 and give them when the platelet count falls below 50x10 9 Early use of platelets should be considered in trauma patients

Massive Haemorrhage call to Obstetric Theatres 11:23 am Monday Morning You are alerted that there is a massive haemorrhage in maternity. Post Partum patient is bleeding heavily. Requests 4 units of blood and 4 units of FFP

The doctor is very impatient What techniques can you use to ensure you get the information you need? Acknowledge that it is important to get the blood products to the patient as quickly as possible so the doctor knows you appreciate the urgency of the situation and that things are probably quite scary his/her end I can hear that this patient needs blood as quickly as possible. To do this I will need the following information

What information do you need from the doctor? Patient Identification details Where the patient is and what the diagnosis is Have any blood samples been taken ( FBC, Coag, Group and save) Who is the named clinical link for this MH and which phone number should you use

What you may be able to tell the doctor... Whether you have a valid sample, if not how many samples needed Does your lab have a 2 sample policy? Ask whether they would like group specific blood or fully crossed matched blood Give approximate time lines for both (dependent on whether there is a valid sample in lab or not) FFP will be available in 40 minutes as has to defrost Tell doctor where emergency O negative blood can be found The availability of platelets if they ask and if you are in a hospital that needs to order platelets Do you always have emergency platelets available Inform the doctor you will phone him/her when the blood is ready or if e issue ask them to send someone straight away

What are your next actions Review computer system for any historic results, special requirements (irradiated, HEV neg, antigen negative) What will you do if the patient does have special requirements and there are no suitable units in stock Issue best match; this is a life saving event Need to flag up to consultant haematologist If no historic blood group what group red cells are you going to issue when you get the first sample? Does the patient need special FFP? If born after 1 st January 1996 then needs MB treated Do you start to defrost group AB or A before you get the first sample? Communicate with other lab colleagues (haematology, chemistry)

The clinical team ask for 4 more units of both blood and FFP. The patient is still bleeding and oozing from multiple sites What do think may be happening clinically? DIC Are you going to ask for coagulation (including fibrinogen) and FBC at this point? Yes Do you need to warn the haematology lab that urgent samples are coming? How do you tell the clinical team to deliver the samples? Do you defrost both FFP and cryo? Cryo dependent on fibrinogen level Do you order the platelets and how many or wait for fbc? If clinical team have requested them before results available Do you act to anticipate further need for blood, this is an evolving and continuing MH, may pay to get ahead and issue further units, could ask another member of staff to crossmatch and issue whilst you sort the platelets and the Cryo? Have the clinical team involved the Consultant Haematologist or do you need to do this?

And finally stand down... After 12 units of blood 4 units of FFP 4 units cryo 4 units platelets How do you feel, do you have a de brief? Do you or your managers liaise with clinical teams as to what went well and what could have gone better?? Does your HTT audit all the MHs

Gotcha s! RD&E experiences Don t give the emergency platelets to a non-emergency patient before the replacement platelets have arrived Don t refuse to issue FFP because you have no coag results (or any other components/products) Don t go off for a tea break whilst in the middle of a crossmatch unless there is good cover and handover Be prepared to help the clinical staff Access to locked fridge Don t get cross with the clinical staff if they turn up in the lab before products are ready Check the blood group of the patient on the computer before selecting components, don t trust a verbal message from another person

DON T PANIC!!